Tuberculosis is an infectious disease, which is caused by the Mycobacterium tuberculosis complex. This disease leads to up to 1.3 million deaths out of more than eight million cases every year. A prodrug called isoniazid has been proven to be effective and widely used in the treatment of infections caused by tuberculosis. Despite its use for more than six decades clinically, the action mechanism of this prodrug is yet to be elucidated. INH action agains mycobacteria requires catalase−peroxidase (KatG) function, and IN-NAD adduct formation is catalyzed in vitro by M. tuberculosis KatG under a variety of conditions. Low-intensity EMF (Electromagnetic Field) has been used in therapeutic practices in addition to its use in telecommunication systems and food protection. EMF is used in medicine and food industries especially for its bacte-ricidal effects. In this study, we aimed to investigate the effects of weak magnetic field application and the addition of NAD and H2O2 on the action mechanism of isoniazid. We added H2O2 and NAD individually and together, to the different groups at varying concentrations. Also, one experimental group was exposed to a 5mT, 50Hz magnetic field for 4 to 5 hours per day (total of 45 hours in 10 days). The agar proportion method was used to evaluate the results. It was determined that the addition of 100 μM NAD and H2O2 together increased the effectiveness of isoniazid to some extent. However, the application of a weak magnetic field did not change the effectiveness of the drug.
___
1. World Health Organization, Global Tuberculosis Report. Executive summary 2018, http://www.who.int/tb/publications/global_report/GraphicExecutiveSummary.pdf?ua=1 2018.
2. Chapter 1Major Infectious Diseases: Key Messages from Disease Control Priorities, Third Edition
3. Winder F 1960 Catalase and peroxidase in mycobacteria. Am Rev Respir Dis. 81:68-78.
4. Awasthy D, Ambady A, Narayana A, et al. Roles of the two type II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitro. Gene. 2014;550:110-6.
5. International Agency for Research on Cancer (IARC). IARC monographs on the evaluation of carcinogenic risk to humans, 2002, vol 80.
6. Cifra M, Fields JZ, Farhadi A.Electromagnetic cellular interactions. Prog Biophys Mol Biol. 2011;105:223-46.
7. Ciejka E, Kleniewska P, Skibska B, et al. Effects of extremely low frequency magnetic field on oxidative balance in brain of rats. J Physiol Pharmacol. 2011;62:657-61.
8. Goraca A, Ciejka E, Piechota A. Effects of extremely low frequency magnetic field on the parameters of oxidative stress in heart.J Physiol Pharmacol. 2010;61:333-8.
9. Mostafa RM, Moustafa YM, Ali FM, et al. Sex hormone status in male rats after exposure to 50 Hz, 5 mTesla magnetic field. Arch Androl. 2006;52:363-9.
10. Saunders RD, Jefferys JG. A neurobiological basis for ELF guidelines. Health Phys. 2007;92:596-603.
11. Batçıoğlu K, Öztürk İÇ, Atalay S, et al. Investigation of time dependent magnetic field effects on superoxide dismutase and catalase activity: an in vitro study. JBPC. 2002;2:1-5.
12. Batçıoğlu K, Doğan M, Uyumlu AB, et al. Investigation of a weak magnetic field effect on the in vitro catalytic activity of adenosine deaminase and xanthine oxidase.Gen. Physiol. Biophys. 2011;30:410-4.
13. Fojt L, Klapetek P, Strasak L, et al. 50 Hz magnetic field effect on the morphology of bacteria. Micron. 2009;40:918-22.
14. Fojt L, Strasak L, Vetterl V, et al. Comparison of the low-frequency magnetic field effects on bacteria Escherichia coli, Leclerciaadecarboxylata and Staphylococcus aureus. Bioelectrochemistry. 2004;63:337-41.
15. Fojt L, Strasak L, Vetterl V. Extremely-low frequency magnetic field effects on sulfate reducing bacteria viability. Electromagn Biol Med. 2010;29:177-85.
16. Cellini L, Grande R, Di Campli E, et al. Bacterial response to the exposure of 50 Hz electromagnetic fields. Bioelectromagnetics. 2008;29:302-11.
17. Strasak L, Vetterl V, Smarda J. Effects of low-frequency magnetic fields on bacteria Escherichia coli. Bioelectrochemistry. 2002;55:161-4.
18. Segatore B, Setacci D, Bennato F, et al. Evaluations of the effects of extremely low-frequency electromagnetic fields on growth and antibiotic susceptibility of escherichia coli and pseudomonas aeruginosa. Int J Microbiol. 2012:587293.
19. Argyrou A, Vetting MW, Blanchard JS. New insight into the mechanism of action of and resistance to isoniazid: Interaction of Mycobacterium tuberculosis enoyl-ACP reductase with INH-NADP. J Amn Chemical Society. 2007;129:9582-3.
20. Zhao XB, Yu H, Yu SW, et al. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant. Biochemistry .2006;45:4131-40.
21. Cade CE, Dlouhy AC, Medzihradszky KF, et al. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. Protein Sci. 2010;19:458-74.